INSIGHTS ON DRUG DEVELOPMENT

• AI Enabled Pharmaceutical Cocrystal Screening

  Cocrystal candidate screening is resource-intensive and prone to gaps. This paper examines how AI-based modeling, trained on more than 20,000 data points, can sharpen candidate prioritization without sacrificing scientific rigor.

• Thermofluor Screening For Injectable Protein Formulations

  The results herein highlight thermofluor screening as a versatile and efficient platform for rational formulation of injectable biologics through the acceleration of stable drug product development.

• NGS In GMP Manufacturing: Reducing Risk, Increasing Return

  Global regulators now recognize NGS as a rigorous, GMP‑ready tool for viral safety, driving a shift toward scalable quality strategies. Learn why NGS is becoming central to modern manufacturing.

• Simplify Your Cell Culture Processes

  Discover bioreactors that combine fast setup, robust design, and scalable performance to streamline cell culture workflows, which help you move from uncertainty to control, no matter your molecule.

• Ask Us Anything: Eric Fang On New Challenges In Pharma Development

  7/24/2026

  Eric Fang on meeting new pharmaceutical development challenges with a two-part investment — technology that answers R&D questions faster, and scientists given the support to tackle what technology can't.

• Characterizing Protein Stability By DSC

  9/24/2026

  Discover how differential scanning calorimetry quantifies the thermodynamic forces behind protein folding and stability, providing valuable insight for protein engineering and therapeutic formulation.

• Multiplex Imaging

  3/24/2025

  Explore recombinant antibody reagents that support the imaging of key targets within the TME and offer flexible solutions across various platforms to improve patient outcomes.

• 3D Cell Culture Reveals Undetectable Drug Efficacy In Traditional Systems

  3/10/2025

  Drug discovery now targets cancer stem cells (CSCs) to achieve long-term tumor eradication, which moves beyond traditional chemotherapeutics. Discover an advanced screening platform that better predicts CSC inhibitor efficacy.

• If Collaboration Fuels Biopharma Innovation, Why Can't We Connect More?

  3/17/2026

  Breakthroughs thrive when biopharma teams work across silos, yet collaboration remains surprisingly difficult. Explore the barriers and why they persist. What will it take to move beyond them?